Full-Time
Biotechnology company focused on drug discovery
No salary listed
Senior, Expert
Daly City, CA, USA
Xaira Therapeutics focuses on improving drug discovery and development through the use of artificial intelligence. The company employs machine learning techniques to analyze biological data, which helps in understanding the underlying mechanisms of diseases. By generating extensive datasets, Xaira can create more accurate models that inform the development of new therapies. What sets Xaira apart from its competitors is its integrated approach that combines advanced AI research, data generation, and therapeutic development all under one roof. The goal of Xaira Therapeutics is to transform the way diseases are treated by making the drug development process more efficient and effective.
Company Size
51-200
Company Stage
Late Stage VC
Total Funding
$1B
Headquarters
Brisbane, California
Founded
2023
Help us improve and share your feedback! Did you find this helpful?
Flexible Work Hours
Stock Options
Company Equity
Isomorphic Lab secured a record-breaking $600 million Series A in March 2025, and Xaira Therapeutics raised $200 million in 2024.
Xaira Therapeutics announced the appointment of Dr. Bo Wang as SVP and Head of Biomedical AI.
Xaira Therapeutics to expand into 73,075 square feet of space in San Francisco California. Xaira Therapeutics to expand into 73,075 square feet of space in San Francisco California.San Francisco, California — According to state and local development sources, Xaira Therapeutics plans to build out 73,075 square feet of new space in San Francisco. The company plans to occupy the new space in San Francisco, on or about July 1, 2025. According to the company website Xaira Therapeutics is an integrated biotechnology company driving advances in artificial intelligence to learn the language of life and transform how we treat disease. The company seeks to rethink the drug discovery and development process from end-to-end by bringing together leading talent across three core areas: machine learning research to better understand biology, expansive data generation to power new models, and robust therapeutic product development to treat disease. Xaira is headquartered in the San Francisco Bay Area.To learn more about Xaira Therapeutics, visit http://xaira.com/Company Contact:Uplaksh Kumar, Chief Operating [email protected]: http://www.intelligence360.ioCopyright (c) 2024 SI360 Inc
Xaira Therapeutics announces the appointment of Dr. Paulo Fontoura as Chief Medical Officer and Dr. Hetu Kamisetty as chief technology officer.
Xaira launched in April with a massive $1 billion round led by ARCH Venture Partners and Foresite Labs (both known for biotech), but with classic Silicon Valley VCs in the round, too, like NEA, Sequoia Capital, Lightspeed Venture Partners, SV Angel, and others.